Addex Therapeutics Ltd
Addex Therapeutics Ltd (ADXN.SW) Stock Competitors & Peer Comparison
See (ADXN.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADXN.SW | CHF 0.04 | -12.27% | 5.8M | -0.64 | -CHF 0.06 | N/A |
| GILD.SW | CHF 109.91 | -4.24% | 137.6B | 20.62 | CHF 5.38 | +2.30% |
| BION.SW | CHF 44.45 | +2.89% | 2.5B | 4.22 | CHF 10.54 | +5.06% |
| MOR.SW | CHF 102.00 | +0.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| KURN.SW | CHF 22.26 | +3.06% | 872.1M | 371.00 | CHF 0.06 | N/A |
| IDIA.SW | CHF 3.47 | +4.52% | 692.5M | -6.67 | -CHF 0.52 | N/A |
| BSLN.SW | CHF 54.40 | +3.42% | 667.6M | 17.32 | CHF 3.14 | N/A |
| NWRN.SW | CHF 15.16 | +1.47% | 303.4M | -25.27 | -CHF 0.60 | N/A |
| SANN.SW | CHF 15.56 | +1.70% | 218.7M | -2.89 | -CHF 5.38 | N/A |
| MOLN.SW | CHF 3.12 | -0.64% | 116.7M | -1.89 | -CHF 1.65 | N/A |
Stock Comparison
ADXN.SW vs GILD.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, GILD.SW has a market cap of 137.6B. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while GILD.SW trades at CHF 109.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas GILD.SW's P/E ratio is 20.62. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to GILD.SW's ROE of +0.26%. Regarding short-term risk, ADXN.SW is more volatile compared to GILD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check GILD.SW's competition here
ADXN.SW vs BION.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, BION.SW has a market cap of 2.5B. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while BION.SW trades at CHF 44.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas BION.SW's P/E ratio is 4.22. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to BION.SW's ROE of -0.13%. Regarding short-term risk, ADXN.SW is more volatile compared to BION.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check BION.SW's competition here
ADXN.SW vs MOR.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while MOR.SW trades at CHF 102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to MOR.SW's ROE of -1.84%. Regarding short-term risk, Volatility data is not available for a full comparison. ADXN.SW has daily volatility of 17.28 and MOR.SW has daily volatility of N/A.Check MOR.SW's competition here
ADXN.SW vs KURN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, KURN.SW has a market cap of 872.1M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while KURN.SW trades at CHF 22.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas KURN.SW's P/E ratio is 371.00. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to KURN.SW's ROE of +0.02%. Regarding short-term risk, ADXN.SW is more volatile compared to KURN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check KURN.SW's competition here
ADXN.SW vs IDIA.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, IDIA.SW has a market cap of 692.5M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while IDIA.SW trades at CHF 3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas IDIA.SW's P/E ratio is -6.67. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to IDIA.SW's ROE of +0.10%. Regarding short-term risk, ADXN.SW is more volatile compared to IDIA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check IDIA.SW's competition here
ADXN.SW vs BSLN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, BSLN.SW has a market cap of 667.6M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while BSLN.SW trades at CHF 54.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas BSLN.SW's P/E ratio is 17.32. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to BSLN.SW's ROE of +0.28%. Regarding short-term risk, ADXN.SW is more volatile compared to BSLN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check BSLN.SW's competition here
ADXN.SW vs NWRN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, NWRN.SW has a market cap of 303.4M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while NWRN.SW trades at CHF 15.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas NWRN.SW's P/E ratio is -25.27. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to NWRN.SW's ROE of +2.78%. Regarding short-term risk, ADXN.SW is more volatile compared to NWRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check NWRN.SW's competition here
ADXN.SW vs SANN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, SANN.SW has a market cap of 218.7M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while SANN.SW trades at CHF 15.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas SANN.SW's P/E ratio is -2.89. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to SANN.SW's ROE of -5.22%. Regarding short-term risk, ADXN.SW is more volatile compared to SANN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check SANN.SW's competition here
ADXN.SW vs MOLN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, MOLN.SW has a market cap of 116.7M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while MOLN.SW trades at CHF 3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas MOLN.SW's P/E ratio is -1.89. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to MOLN.SW's ROE of -0.60%. Regarding short-term risk, ADXN.SW is more volatile compared to MOLN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check MOLN.SW's competition here
ADXN.SW vs MMTX.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, MMTX.SW has a market cap of 49.4M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while MMTX.SW trades at CHF 0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas MMTX.SW's P/E ratio is N/A. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to MMTX.SW's ROE of N/A. Regarding short-term risk, ADXN.SW is less volatile compared to MMTX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for ADXN.SW.Check MMTX.SW's competition here
ADXN.SW vs RLF.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, RLF.SW has a market cap of 36.3M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while RLF.SW trades at CHF 2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas RLF.SW's P/E ratio is -2.12. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to RLF.SW's ROE of -0.49%. Regarding short-term risk, ADXN.SW is more volatile compared to RLF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check RLF.SW's competition here
ADXN.SW vs EVE.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, EVE.SW has a market cap of 6.6M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while EVE.SW trades at CHF 0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas EVE.SW's P/E ratio is -7.58. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to EVE.SW's ROE of -0.13%. Regarding short-term risk, ADXN.SW is more volatile compared to EVE.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check EVE.SW's competition here
ADXN.SW vs SPEX.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, ADXN.SW is more volatile compared to SPEX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check SPEX.SW's competition here
ADXN.SW vs OBSN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, ADXN.SW is less volatile compared to OBSN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for ADXN.SW.Check OBSN.SW's competition here
ADXN.SW vs POLN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, ADXN.SW is more volatile compared to POLN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check POLN.SW's competition here
ADXN.SW vs SKIN.SW Comparison April 2026
ADXN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADXN.SW stands at 5.8M. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, ADXN.SW is priced at CHF 0.04, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADXN.SW currently has a P/E ratio of -0.64, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, ADXN.SW's ROE is -0.78%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, ADXN.SW is more volatile compared to SKIN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ADXN.SW.Check SKIN.SW's competition here